Evidence map›Paper›PMID 42788365›Full record

ArticleMolecular medicine reports2026

[Retracted] CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Long-Qiao Cao, Ya-Nan Wang, Ming Liang, Mei-Zhou Pan

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Long-Qiao CaoReproductive Medical Center, The First People's Hospital of Jining, Jining, Shandong 272100, P.R. China.
Ya-Nan WangReproductive Medical Center, The Second Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong 251400, P.R. China.
Ming LiangReproductive Medical Center, The Second Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong 251400, P.R. China.
Mei-Zhou PanDepartment of Urology Surgery, The Seventh People's Hospital of Jinan, Jinan, Shandong 251400, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the p16 antibody that the authors reported to have used for the western blot experiment shown in Fig. 4B (cat. no. ab51243) is specific for the protein known as P16 ARC (or ARPC5), not the apoptosis‑associated protein p16INK4a, as was intended. Furthermore, upon performing an independent analysis of the data in this paper in the Editorial Office, it came to light that western blot data featured in Fig. 5 were strikingly similar to data that had already been published in a different paper in the journal

Indexed as

calbindin 1MdM2 proto-oncogeneovarian cancerp53senescence

Identifiers

PMID42788365
PMCPMC13631837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.